NEW Own OGN? Track every OGN payout — and your other stocks

Track your stocks, dividends, monitor DRIP shares, and project your passive income.

Start Free »

Organon & Co. OGN | NYSE

$13.68 $0.00 | 0.00%

Next Earnings: Sep 15, 2026

Company Overview:

Market Cap: $0

Trailing PE: 0x

FWD PE *: 3.8x

Payout Ratio (TTM): 8.6%

52-Week Range: $5.69 - $13.79

* Forward PE is based on street estimates.

5.3 Year OGN Performance Metrics:

Total Return (with DRIP): -49.4% (-12.06% CAGR)

Total Return (no DRIP): -45.9% (-10.93% CAGR)

Share Price: -58.9% (-15.43% CAGR)

Yield on Cost (with DRIP): 0.30%

Total Invested: $10,000

Total Value (with DRIP): $5,060

Total Return $ (with DRIP): -$4,940

Dividend Increase: -92.9% (-41.12% CAGR)

Dividend Yield (FWD): 0.58% ($0.08)

OGN 5.3-yr Total Return ($10K invested)

1Y 2Y 5Y 10Y All

OGN Share Price chart

Share Price

OGN Price CAGR:1Y: 31.54%2Y: -19.06%5Y: -16.51%10Y: -15.33%

OGN Dividend Charts

OGN - Dividends

OGN Dividend CAGR:1Y: 0.00%2Y: -73.27%5Y: -41.01%10Y: -41.12%

OGN - Dividend Payout Ratio

OGN - Dividend to Free Cash Flow Ratio

Unlock All Reports & Research Dividend Stocks.

Save 25% with annual plan (3 Months Free)

Pro

$171/yr ($14.25/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Stock Fundamentals
DCF valuation modeling
Compare Stocks Side-by-Side
Revenue & EPS Estimates

Start Free Trial

You save $57/yr (25%)

OGN Earnings, Revenue, Cash & Debt, Shares Outstanding:

OGN - Revenue

OGN Revenue CAGR:1Y: -2.26%2Y: -1.54%5Y: -0.75%10Y: 0.00%

OGN - Earnings Per Share (EPS)

OGN EPS CAGR:1Y: -28.57%2Y: -26.97%5Y: -24.95%10Y: 0.00%

OGN - Net Income

🔒 Unlock

OGN Net Income CAGR:1Y: -25.52%2Y: -25.58%5Y: -24.04%10Y: 0.00%

OGN - EBITDA

🔒 Unlock

OGN EBITDA CAGR:1Y: -17.37%2Y: -7.33%5Y: -7.30%10Y: 0.00%

OGN - Free Cash Flow

🔒 Unlock

OGN Free Cash Flow CAGR:1Y: -64.09%2Y: -53.45%5Y: -45.98%10Y: 0.00%

OGN - Free Cash Flow / Share

🔒 Unlock

OGN Free Cash Flow / Share CAGR:1Y: -64.45%2Y: -53.93%5Y: -46.36%10Y: 0.00%

OGN - Operating Income

🔒 Unlock

OGN Operating Income CAGR:1Y: -0.92%2Y: -8.52%5Y: -9.87%10Y: 0.00%

OGN - Gross Profit

🔒 Unlock

OGN Gross Profit CAGR:1Y: -3.09%2Y: -5.03%5Y: -3.93%10Y: 0.00%

OGN - Shares Outstanding

🔒 Unlock

OGN Shares Outstanding CAGR:1Y: 3.96%2Y: 2.27%5Y: 1.28%10Y: 0.00%

OGN - Share Buybacks

🔒 Unlock

OGN Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

OGN - Stock-Based Comp

🔒 Unlock

OGN Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

OGN - Expenses

🔒 Unlock

OGN Expenses CAGR:1Y: 7.69%2Y: 14.56%5Y: -6.57%10Y: 0.00%

OGN - Revenue vs Net Income

🔒 Unlock

OGN - EPS vs FCF / Share

🔒 Unlock

OGN - EPS vs PE Ratio

🔒 Unlock

OGN - FCF vs FCF / Share

🔒 Unlock

OGN - FCF vs Stock Based Comp

🔒 Unlock

OGN - Cash & Debt

🔒 Unlock

OGN - Revenue by Region

🔒 Unlock

OGN Revenue CAGR:1Y: -2.26%2Y: -1.54%5Y: -0.75%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

OGN - REVENUE: Actual + Estimates

🔒 Unlock

OGN Actual Revenue CAGR:1Y: -2.26%2Y: -1.54%5Y: -0.75%10Y: 0.00%

OGN - EPS: Actual + Estimates

🔒 Unlock

OGN Actual EPS CAGR:1Y: -28.57%2Y: -26.97%5Y: -24.95%10Y: 0.00%

OGN - NET INCOME: Actual + Estimates

🔒 Unlock

OGN Actual Net Income CAGR:1Y: -25.52%2Y: -25.58%5Y: -24.04%10Y: 0.00%

OGN - EBITDA: Actual + Estimates

🔒 Unlock

OGN Actual EBITDA CAGR:1Y: -17.37%2Y: -7.33%5Y: -7.30%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

OGN - Net Profit Margin

🔒 Unlock

OGN Net Profit Margin CAGR:1Y: -23.85%2Y: -24.41%5Y: -23.47%10Y: 0.00%

OGN - Gross Profit Margin

🔒 Unlock

OGN Gross Profit Margin CAGR:1Y: -0.86%2Y: -3.55%5Y: -3.20%10Y: 0.00%

OGN - Price to Earnings

🔒 Unlock

OGN - Price To Sales Ratio

🔒 Unlock

OGN - Return on Capital Employed

🔒 Unlock

OGN - Return on Invested Capital

🔒 Unlock

OGN Dividends Info:

Annual Dividend: $0.08

Forward Yield: 0.58%

Ex-Dividend Date: 2026-08-14

Lifetime Dividends / Share: $4.32

OGN Dividend History: Dates, Payments & Yield list

Below is a schedule of all OGN dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date	Payment Date	Amount	Yield	Forward Yield	Price on Ex-Date
08/14/2026	08/17/2026	$0.020	0.58%	0.58%	$13.70
05/11/2026	05/13/2026	$0.020	0.6%	0.6%	$13.34
02/23/2026	02/25/2026	$0.020	1.01%	1.07%	$7.51
11/20/2025	11/24/2025	$0.020	1.12%	1.13%	$7.06
08/15/2025	08/18/2025	$0.020	0.85%	0.86%	$9.28
05/12/2025	05/14/2025	$0.020	0.92%	1%	$8.04
02/24/2025	02/26/2025	$0.280	7.43%	7.24%	$15.48
11/12/2024	11/14/2024	$0.280	7.19%	7.32%	$15.31
08/16/2024	08/19/2024	$0.280	5.5%	5.34%	$20.96
05/10/2024	05/13/2024	$0.280	5.48%	5.35%	$20.94
02/23/2024	02/26/2024	$0.280	6.05%	6.35%	$17.65
11/10/2023	11/13/2023	$0.280	10.07%	10.15%	$11.03
08/17/2023	08/21/2023	$0.280	4.99%	5%	$22.40
05/12/2023	05/15/2023	$0.280	5.37%	5.37%	$20.84
02/24/2023	02/27/2023	$0.280	4.38%	4.46%	$25.09
11/10/2022	12/15/2022	$0.280	4.53%	3.96%	$28.28
08/12/2022	09/15/2022	$0.280	3.61%	3.9%	$28.75
05/13/2022	06/16/2022	$0.280	3.21%	3.41%	$32.81
02/25/2022	03/17/2022	$0.280	2.98%	3.26%	$34.34
11/19/2021	12/16/2021	$0.280	3.58%	3.69%	$30.33
08/20/2021	09/13/2021	$0.280	3.37%	3.31%	$33.83

Projected Future Returns & Dividends for OGN

Based on past 5.3-year performance, here are OGN growth metrics:

Share price CAGR of -15.43%
Dividend CAGR of -41.48%

Using OGN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, is modelled to grow as follows:

	OGN (DRIP)	OGN - No DRIP
Current Price	$13.68	$13.68
Start Shares	730.99	730.99
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	744.64	730.99
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$2.56	$2.56
Total Dividends	$141	$140
Final Value	$1,907	$2,012

Estimated Future Value + Dividends - OGN

NOTE: Above numbers are our estimate based on OGN's Dividend and Price CAGR over past 5.3 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

Pro

$171/yr ($14.25/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Stock Fundamentals
DCF valuation modeling
Compare Stocks Side-by-Side
Revenue & EPS Estimates

Start Free Trial

You save $57/yr (25%)

Company Info

Organon & Co. (OGN) had its IPO on 2021-05-14, and is trader on NYSE stock exchange.

Organon & Co., a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies. Its women's health division features reproductive care products, encompassing birth control and fertility treatments, notably Nexplanon/Implanon, an extended-duration contraceptive. The company's biosimilars collection includes three immune-related medications (Brenzys, Renflexis, Hadlima) and two cancer therapies (Ontruzant, Aybintio). Additionally, Organon provides cardiovascular medications, such as cholesterol-reducing drugs (Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, Zocor) and treatments for high blood pressure (Cozaar, Hyzaar). Their respiratory product line addresses asthma symptoms with brands like Singulair, Dulera, Zenhale, and Asmanex, and manages seasonal allergies through Singulair, Nasonex, Clarinex, and Aerius. Furthermore, their offerings extend to dermatological care (Diprosone, Elocon), bone strengthening (Fosamax), and non-narcotic pain relief (Arcoxia, Diprospan, Celestone). The portfolio also comprises Proscar for treating symptomatic benign prostatic hyperplasia and Propecia for combating male pattern hair loss. The company's products are primarily distributed to pharmaceutical wholesalers, retailers, medical facilities, government entities, and various managed healthcare organizations, including health maintenance organizations and pharmacy benefit managers. Organon & Co. was established in 2020 and is headquartered in Jersey City, New Jersey.

OGN website: https://www.organon.com

Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)

Pro

$171/yr ($14.25/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Stock Fundamentals
DCF valuation modeling
Compare Stocks Side-by-Side
Revenue & EPS Estimates

Start Free Trial

You save $57/yr (25%)